Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nasdaq warns Cardima over listing requirements

This article was originally published in Clinica

Executive Summary

Cardima's ailing fortunes could soon spell a delisting from the US stock exchange. The Fremont, California-based company has received written notice from Nasdaq that, following a review of its third-quarter results for the period ended September 30 2004 and of its listed securities' market value, the firm had fallen below the minimum requirements to remain eligible for listing on the market.

Topics

UsernamePublicRestriction

Register

MT060262

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel